Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is a paper indexed in PICO Portal from OpenAlex.

How many citations does Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective have?

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has 124 citations in the OpenAlex counts PICO Portal stores.

When was Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective published?

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has 2020 year in the PICO Portal index.

What is the open-access status of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?

Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective has closed oa status in the PICO Portal index.

What is the DOI of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?

The DOI for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.

What is the PMID of Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?

The PMID for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.

What is the OpenAlex record for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective?

The OpenAlex for Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective is on the source record.